These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 33385008)

  • 1. Probiotics as a Weapon in the Fight Against COVID-19.
    Stavropoulou E; Bezirtzoglou E
    Front Nutr; 2020; 7():614986. PubMed ID: 33385008
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hygiene as a weapon in the fight against SARS-Cov-2. All experts in taking care!].
    Litaize A; Heuchon Y; Perez P; Clervoy P; Lefort H
    Soins; 2020 Oct; 65(849):32-37. PubMed ID: 33357615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are probiotics effective adjuvant therapeutic choice in patients with COVID-19?
    Di Renzo L; Merra G; Esposito E; De Lorenzo A
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4062-4063. PubMed ID: 32374010
    [No Abstract]   [Full Text] [Related]  

  • 4. Accurate Diagnosis of COVID-19 by a Novel Immunogenic Secreted SARS-CoV-2 orf8 Protein.
    Wang X; Lam JY; Wong WM; Yuen CK; Cai JP; Au SW; Chan JF; To KKW; Kok KH; Yuen KY
    mBio; 2020 Oct; 11(5):. PubMed ID: 33082264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Considerations for Gut Microbiota and Probiotics in Patients with Diabetes Amidst the Covid-19 Pandemic: A Narrative Review.
    Barengolts E; Smith ED
    Endocr Pract; 2020 Oct; 26(10):1186-1195. PubMed ID: 33471720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comment] Treatment strategies to fight the new coronavirus SARS-CoV-2: A challenge for a Rubik's Cube solver.
    Tsitoura E; Bibaki E; Bolaki M; Vasarmidi E; Trachalaki A; Symvoulakis EK; Spandidos DA; Antoniou KM
    Exp Ther Med; 2020 Jul; 20(1):147-150. PubMed ID: 32536988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Weapon-carrying, physical fighting, and fight-related injury among U.S. adolescents.
    Lowry R; Powell KE; Kann L; Collins JL; Kolbe LJ
    Am J Prev Med; 1998 Feb; 14(2):122-9. PubMed ID: 9631164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutralizing and binding activities against SARS-CoV-1/2, MERS-CoV, and human coronaviruses 229E and OC43 by normal human intravenous immunoglobulin derived from healthy donors in Japan.
    Kubota-Koketsu R; Terada Y; Yunoki M; Sasaki T; Nakayama EE; Kamitani W; Shioda T
    Transfusion; 2021 Feb; 61(2):356-360. PubMed ID: 33104267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
    Stratton CW; Tang YW; Lu H
    J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Case Study: Analysis of Patents on Coronaviruses and Covid-19 for Technological Assessment and Future Research.
    Musyuni P; Aggarwal G; Nagpal M; Goyal RK
    Curr Pharm Des; 2021; 27(3):423-439. PubMed ID: 32693757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Emergence of Human Pathogenic Coronaviruses: Lectins as Antivirals for SARS-CoV-2.
    Sohrab SS; Suhail M; Kamal MA; Ahmad F; Azhar EI
    Curr Pharm Des; 2020; 26(41):5286-5292. PubMed ID: 32954998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19.
    Braun J; Loyal L; Frentsch M; Wendisch D; Georg P; Kurth F; Hippenstiel S; Dingeldey M; Kruse B; Fauchere F; Baysal E; Mangold M; Henze L; Lauster R; Mall MA; Beyer K; Röhmel J; Voigt S; Schmitz J; Miltenyi S; Demuth I; Müller MA; Hocke A; Witzenrath M; Suttorp N; Kern F; Reimer U; Wenschuh H; Drosten C; Corman VM; Giesecke-Thiel C; Sander LE; Thiel A
    Nature; 2020 Nov; 587(7833):270-274. PubMed ID: 32726801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human Milk Antibodies Against S1 and S2 Subunits from SARS-CoV-2, HCoV-OC43, and HCoV-229E in Mothers with A Confirmed COVID-19 PCR, Viral SYMPTOMS, and Unexposed Mothers.
    Demers-Mathieu V; DaPra C; Mathijssen G; A Sela D; M Jarvinen K; Seppo A; Fels S; Medo E
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33572480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probiotics and COVID-19.
    Ceccarelli G; Scagnolari C; Pugliese F; Mastroianni CM; d'Ettorre G
    Lancet Gastroenterol Hepatol; 2020 Aug; 5(8):721-722. PubMed ID: 32673604
    [No Abstract]   [Full Text] [Related]  

  • 15. Probiotics and COVID-19.
    Giannoni E; Baud D; Agri VD; Gibson GR; Reid G
    Lancet Gastroenterol Hepatol; 2020 Aug; 5(8):720-721. PubMed ID: 32673603
    [No Abstract]   [Full Text] [Related]  

  • 16. [Source of the COVID-19 pandemic: ecology and genetics of coronaviruses (Betacoronavirus: Coronaviridae) SARS-CoV, SARS-CoV-2 (subgenus Sarbecovirus), and MERS-CoV (subgenus Merbecovirus).].
    Lvov DK; Alkhovsky SV
    Vopr Virusol; 2020; 65(2):62-70. PubMed ID: 32515561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probiotics and COVID-19 - Authors' reply.
    Mak JWY; Chan FKL; Ng SC
    Lancet Gastroenterol Hepatol; 2020 Aug; 5(8):722-723. PubMed ID: 32673605
    [No Abstract]   [Full Text] [Related]  

  • 18. Intestinal Flora as a Potential Strategy to Fight SARS-CoV-2 Infection.
    He LH; Ren LF; Li JF; Wu YN; Li X; Zhang L
    Front Microbiol; 2020; 11():1388. PubMed ID: 32582138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiviral Potential of Nanoparticles-Can Nanoparticles Fight Against Coronaviruses?
    Gurunathan S; Qasim M; Choi Y; Do JT; Park C; Hong K; Kim JH; Song H
    Nanomaterials (Basel); 2020 Aug; 10(9):. PubMed ID: 32825737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of probiotics in COVID-19 treatment: Gut microbiota can help physicians in the outbreak.
    Şahin M
    Turk J Gastroenterol; 2020 Oct; 31(10):724-725. PubMed ID: 33169711
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.